Intelligence · Clinical Pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
- Programs
- 5,427
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
-
Cemdisiran
Regeneron UK Limited
Paroxysmal Nocturnal Hemoglobinuria
1 trial -
Cemdisiran, Pozelimab
Lacuna Pharma Pty Ltd
Paroxysmal nocturnal hemoglobinuria (PNH)
1 trial -
Cemiplimab
Regeneron UK Limited
Squamous Cell Carcinoma (SCC)
1 trial -
Cemiplimab
Regeneron UK Limited
Cutaneous Squamous Cell Carcinoma
7 trials -
Cemiplimab
Regeneron UK Limited
Cutaneous Squamous Cell Carcinoma (CSCC)
1 trial -
Cemiplimab
Regeneron UK Limited
Recurrent Lung Non-Small Cell Carcinoma
1 trial -
Cendakimab
Celgene Europe Limited
Eosinophilic esophagitis
1 trial -
Cenerimod
Viatris Pharmaceuticals Co.,
Lupus Erythematosus, Systemic
2 trials -
Cenerimod 4 mg
Viatris Pharmaceuticals Co.,
Systemic lupus erythematosus
1 trial -
Cenerimod 4 mg, Cenerimod matching placebo
Viatris Pharmaceuticals Co.,
Moderate to severe systemic lupus erythematosus
1 trial -
Cenerimod matching placebo, Cenerimod 4 mg
Viatris Pharmaceuticals Co.,
Moderate to severe systemic lupus erythematosus
1 trial -
Cenestin 0.3 mg Tablets
Teva Pharma GmbH
Hot Flashes
1 trial -
Cerezyme 400 Units Powder for concentrate for solution for infusion, Placebo 15mg tablets, venglustat GZ402671 - SAR402671, Placebo 6mg tablets, Cerezyme 400 Units Powder for concentrate for solution for infusion, Placebo for Cerezyme, Cerezyme 400 Units Powder for concentrate for solution for infusion, venglustat GZ402671 - SAR402671
Sanofi-aventis Healthcare Pty Ltd
Gaucher's disease type III
1 trial -
Cervarix™
GlaxoSmithKline
Infections, Papillomavirus
1 trial -
Cetirizine
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial -
Cetuximab
Amgen
Metastatic Colorectal Cancer
1 trial -
Champix
Hospital Authority, Hong Kong
Tobacco Use Disorder
1 trial -
Chemotherapy
United Therapeutics Europe Ltd
Transitional Cell Carcinoma of Ureter
1 trial -
Chemotherapy
The First People's Hospital of Lianyungang
Acute Lymphoblastic Leukemia
1 trial -
Chemotherapy
International Peace Maternity and Child Health Hospital
Non Small Cell Lung Cancer
1 trial -
Chemotherapy
Sun Yat-sen University
Nasopharyngeal Carcinoma
1 trial -
Chemotherapy
The First People's Hospital of Lianyungang
Endometrial Cancer
1 trial -
Chemotherapy + avelumab followed by avelumab + talazoparib
Pfizer
Ovarian Cancer
1 trial -
Chemotherapy drug
Chinese PLA General Hospital
Gastric Cancer
1 trial -
Chestnut Bloomington Outpatient (CBOP)
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Chickenpox Vaccines
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chickenpox Vaccines
1 trial -
ChimeriVax-JE, Japanese Encephalitis vaccine
Sanofi Pasteur
Encephalitis
1 trial -
Chirhostim
The George Institute
Pancreatic cancer, Intraductal papillary mucinous intraductal neoplasia
1 trial -
Chlorhexidine
United Therapeutics Europe Ltd
Infant, Newborn, Diseases
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Asthma
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
Cholecalciferol (Vitamin D/Vigantol oil)
United Therapeutics Europe Ltd
Respiratory Tract Infections
1 trial -
Cholic Acid
Mirum Pharmaceuticals International B.V.
Bile Acid Synthesis Defect
1 trial -
Cholic Acids
Mirum Pharmaceuticals International B.V.
Infantile Refsum's Disease
1 trial -
Cholic acid
Mirum Pharmaceuticals International B.V.
Inborn Errors of Bile Acid Synthesis
1 trial -
Choline Chloride for Injection
Protara Therapeutics
Choline Deficiency
1 trial -
Chronocort®
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
5 trials -
Cibinqo 100 mg film-coated tablets, Placebo for Abrocitinib 100mg tablet
Pfizer Australia Pty Ltd
Moderate to severe atopic dermatitis
1 trial -
Cidofovir, Brincidofovir
Lacuna Pharma Pty Ltd
Adenovirus viremia
1 trial -
Cilostazol-Elpen 100 mg Tabletten, Placebo de Cilostazol-Elpen 100mg, comprimé
Pari Pharma GmbH
Aneurysmal Subarachnoid Hemorrhage
1 trial -
Cilta-cel
Janssen Cilag International NV
Multiple Myeloma
1 trial -
Cimzia 200 mg solution for injection in pre-filled syringe, SODIUM CHLORIDE
Pari Pharma GmbH
Adult women with recurrent implantation failures (RIF)
1 trial -
Cinryze®
Takeda
Acute Antibody-Mediated Rejection (AMR)
1 trial -
Cipaglucosidase Alfa
AMICUS THERAPEUTICS PTY LTD
Pompe Disease (Late-onset)
1 trial -
Ciprofloxacin (BAYQ3939) dry powder for inhalation
Bayer HealthCare AG
Bronchiectasis
1 trial -
Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Cisplatin
Children's Hospital of Fudan University
Localized Osteosarcoma
1 trial -
Cisplatin
BRIGHT MINDS BIOSCIENCES INC.
Squamous Cell Carcinoma of Head and Neck
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs